Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Infections × gilteritinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 43 Recurrence 6 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Leukemia, Myeloid 2 Leukemia 2 Hematologic Neoplasms 2 Targeted Therapy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Infections 1 Disease 1 Advanced Solid Tumors 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 8 Ciprofloxacin 7 Voriconazole 4 Vancomycin 4 Fluconazole 3 Filgrastim 3 Daptomycin 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Trimethoprim 2 Therapeutics 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Polymerase Chain Reaction 2 Piperacillin, Tazobactam Drug Combination 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Moxifloxacin 2 Melphalan 2 Levofloxacin 2 Lenalidomide 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Ethanol 2 Cyclophosphamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05791890 2023-03-30

GilteRInf

University of Rome Tor Vergata

Other hematologic neoplasm

Infections, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡